Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1573, 2007-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Sunitinib has demonstrated efficacy for the treatment of patients with neuroendocrine tumours
Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. :
LY 686017, a selective neurokinin 1 receptor antagonist, has demonstrated potential for alcoholism.
Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. :
OGT 918 has potential in Gaucher's disease
Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. :
A semiallogeneic cancer vaccine has potential in the treatment of cancer
Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. :